RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) Meeting Abstract
| Authors: | Rudin, C. M.; Dowlati, A.; Chen, Y.; Mendivil, A. F. Navarro; Yang, J. C. H.; Stojanovic, G.; Rich, P.; Andric, Z. G.; Wu, Y. L.; Chen, H.; Zhang, L.; Yeung, S.; Benzaghou, F. M.; Paz-Ares, L.; Bunn, P. A. |
| Abstract Title: | RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) |
| Meeting Title: | 2023 European Lung Cancer Congress |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Mar 29-Apr 1 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | S129 |
| End Page: | S130 |
| Language: | English |
| DOI: | 10.1016/s1556-0864(23)00415-x |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 161O -- Source: Cinahl |
